INSYGMA NUTRITIONWe tested several Omega‑3 products on the market. The results force an uncomfortable question.
The market talks about purity, concentration and "premium quality". But when it comes to Omega‑3, the question that really matters is a different one: what is the oxidative condition of the oil inside the capsule?
The Problem Isn’t on the Label. It’s in the Oil.
When it comes to Omega‑3, it is not enough to trust the brand name, the packaging design or a vague claim about quality control. What really matters is whether the oil reached the consumer in good condition — that is, without significant oxidation.
With that goal in mind, we sent several Omega‑3 samples, purchased at Portuguese points of sale, for independent laboratory analysis (Mérieux NutriSciences). The results showed what too many brands avoid discussing: the actual oxidative condition of the product that reaches the consumer.
One of the samples analyzed, from one of Portugal’s best-selling brands, showed TOTOX 20, with PV 4.8 meq/kg and p-Anisidine 10.6 — above the TOTOX criterion in the cited IFOS report (≤ 19.5).[1]
We're talking about a brand with strong market presence, a credibility-driven narrative and lab-testing claims. Even so, the sample was above the TOTOX criterion in the cited IFOS report. This shows that the a brand's popularity is not, by itself, a guarantee of real oxidative control.
Oxidation Glossary
But who exactly is IFOS, anyway?
IFOS (International Fish Oil Standards) is an SGS Nutrasource certification program that assesses omega-3 content, contaminants and stability. The program’s criteria and reports can serve as a benchmark for comparison; an analysis commissioned by INSYGMA does not amount to IFOS certification.[1]
In this comparison, laboratory values are assessed against criteria published by the IFOS program. This allows parameters to be compared, but does not grant or withdraw certification or, on its own, establish the clinical risk of a product.
| Sample | TOTOX | PV (meq/kg) | p-Anisidine | Status |
|---|---|---|---|---|
| Brand A — best-selling in Portugal | 20,0 | 4,8 | 10,6 | Above the cited criterion |
| Brand B — popular in Portugal | 16,0 | 3,1 | 9,4 | Within the Limit |
| INSYGMA Omega-3 | 13,0 | 1,9 | 8,8 | Cleanest Profile |
The full Certificates of Analysis are available in the documentation section below.
Samples were purchased from Portuguese retailers in sealed packaging, within their expiry date, and testing was commissioned by INSYGMA. The reports were issued by Silliker Portugal — Mérieux NutriSciences. The accreditation scope, method, uncertainty and limitations applicable to each test should be checked in the full PDFs. This comparison of three samples does not represent every batch from the brands or the entire market.
What Does the Literature Say?
Published research on the freshness of Omega‑3 supplements sold to consumers converges on one point that is uncomfortable for the market: the variability is very high. Studies that analyzed samples sold in various countries documented that a a significant fraction of the products exceeded the oxidation limits accepted by international benchmarks. [2][3]
This confirms that consumers should not assume quality based solely on packaging, price, or brand awareness. Not all Omega‑3 products reach the consumer in the same condition.
When one of Portugal’s best-selling brands records TOTOX 20 in an independent analysis, the problem stops being theoretical. It becomes measurable and documented.
Oxidation: what the studies allow us to conclude
Oxidation changes the oil and produces peroxides and secondary products, including aldehydes. These parameters are relevant to assessing quality and stability. However, a TOTOX value alone cannot establish the clinical risk of a capsule or show that the analyzed sample will cause disease.[7]
In a seven-week trial completed by 54 participants, the less oxidized oil had a more favorable effect on IDL and LDL subfractions than the oxidized oil or the control. The study assessed lipid markers, not cardiovascular events, and does not demonstrate that any oxidized oil raises cholesterol or cancels out all benefits.[4]
Malondialdehyde was identified as a weak mutagen in a bacterial assay.[5] Another study observed putative MDA adducts in breast tissue DNA, with differences between groups of women.[6] Neither study tested the supplements in this comparison or demonstrates that consuming them causes cancer.
Our interpretation: it is worth asking for clear laboratory results and proper storage. The cited studies justify paying attention to oxidation, but do not demonstrate that any value above a quality criterion eliminates benefits or causes clinical harm.
The Question You Should Ask Before Buying
When it comes to Omega-3, what should matter isn't the price or the reputation. It's the existence of real, independent, and accessible laboratory proof.
Because with Omega-3, the problem is rarely in the label's promise. It's in the actual state of the oil inside the capsule.
That's why the right question isn't "how many mg does it have?" or "how much EPA and DHA does it have?", but rather: is there a Certificate of Analysis? Is the lab independent? Was the batch identified? Were the PV, p-Anisidine and TOTOX values shown clearly? Does the brand publish the data, or does it simply ask for trust? When these answers don't exist, the consumer depends on faith alone.
The INSYGMA Omega-3 showed TOTOX 13, PV 1.9, and p-Anisidine 8.8. The Certificates of Analysis are published and accessible to anyone.
- IFOS (International Fish Oil Standards). Comparison criteria taken from the official report for batch UC230420 (manufactured 10/2023): PV ≤ 5 meq/kg, p-anisidine ≤ 20, TOTOX ≤ 19.5. These values identify the benchmark used in this comparison; they do not constitute a certification statement for the products analyzed. Certificates of Analysis for the competitor samples: MXNS CoA #3037682 — Brand A (Jan 2026) · MXNS CoA #3037683 — Brand B (Jan 2026)
- Albert, B.B. et al. (2015). Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Scientific Reports, 5, 7928. PubMed
- Jackowski, S.A. et al. (2015). Oxidation levels of North American over-the-counter n-3 (omega-3) supplements and the influence of supplement formulation and delivery form on evaluating oxidative safety. Journal of Nutritional Science, 4, e30. PubMed
- Rundblad, A. et al. (2017). High-quality fish oil has a more favourable effect than oxidised fish oil on intermediate-density lipoprotein and LDL subclasses: a randomised controlled trial. British Journal of Nutrition, 117(9), 1291-1298. PubMed
- Basu, A. K., & Marnett, L. J. (1983). Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis, 4(3), 331-333. PubMed
- Wang, M. et al. (1996). Lipid Peroxidation-induced Putative Malondialdehyde-DNA Adducts in Human Breast Tissues. Cancer Epidemiology, Biomarkers & Prevention, 5(9), 705-710. PubMed
- Rupp, T. P. et al. (2013). Replacement of Reduced Highly Unsaturated Fatty Acids (HUFA Deficiency) in Dilative Heart Failure: Dosage of EPA/DHA and Variability of Adverse Peroxides and Aldehydes in Dietary Supplement Fish Oils. Cardiology, 125(4), 223-231. PubMed